Long-Term in vitro Growth of Human Insulin-Secreting Insulinoma Cells
Authors:
- Wolfgang GartnerWGWolfgang Gartner
- Filiz KocFKFiliz Koc
- Anastasya NabokikhANAnastasya Nabokikh
- Teodora DanevaTDTeodora Daneva
- Bruno NiederleBNBruno Niederle
- Anton LugerALAnton Luger
- Ludwig WagnerLWLudwig Wagner
- 1 August 2006
- journal article
- research article
- Published by S. Karger AG in Neuroendocrinology
- Vol. 83 (2) , 123-130
Abstract
Objective: Long-term in vitro maintenance of human insulin-secreting insulinoma cells. Methods: (1) Cell culture of ex vivo-derived insulinoma cell suspensions from 8 individual human donors, using various cell culture medium supplementations; (2) determination of insulin synthesis and secretion using immunocytochemistry and insulin and pro-insulin radioimmunoassays; (3) nestin-immunostaining of long-term in vitro grown insulinoma cell suspensions, and (4) phase-contrast light microscopy for analyzing the in vitro growth characteristics of the insulinoma cells. Results: (1) Parallel persistence of in vitro insulinoma cell proliferation as well as insulin-synthesizing and -secreting capacity depended on both the co-culture of insulinoma cells with human fibroblasts and the supplementation of the cell culture medium with tissue culture supernatant derived from the rodent pituitary adenoma cell line GH-3; (2) immunostaining for insulin and secretagogin confirmed the neuroendocrine origin of the insulinoma cells grown in vitro; (3) insulin secretion capability persisted up to an observation period of 25 weeks; (4) insulin secretion rates after 6 weeks of in vitro growth ranged from 3.5 to 83.3 µU/ml/h/60,000 cells plated, and (5) after long-term in vitro growth of insulinoma-derived cell suspensions with persistent insulin-secreting capacity, nestin staining was observed predominantly in co-cultured fibroblasts. Conclusion: Our data describe for the first time the long-term in vitro culture of insulin-secreting human insulinomas and highlight the importance of β-cell trophic factors for insulinoma cell growth.Keywords
This publication has 49 references indexed in Scilit:
- STAT5 activation by human GH protects insulin-producing cells against interleukin-1β, interferon-γ and tumour necrosis factor-α-induced apoptosis independent of nitric oxide productionJournal of Endocrinology, 2005
- New sources of pancreatic β-cellsNature Biotechnology, 2005
- Redifferentiation of insulin-secreting cells after in vitro expansion of adult human pancreatic islet tissueBiochemical and Biophysical Research Communications, 2005
- Pituitary cell lines and their endocrine applicationsMolecular and Cellular Endocrinology, 2004
- Insulinomas and expression of an insulin splice variantThe Lancet, 2004
- Altered Expression of HES-1, BETA2/NeuroD, and PDX-1 Is Involved in Impaired Insulin Synthesis Induced by Glucocorticoids in HIT-T15 CellsBiochemical and Biophysical Research Communications, 2001
- Nestin-Expressing Cells in the Pancreatic Islets of LangerhansBiochemical and Biophysical Research Communications, 2000
- Development of engineered pancreatic β-cell lines for cell therapy of diabetesAdvanced Drug Delivery Reviews, 1998
- Expression and regulation of growth hormone (GH) and prolactin (PRL) receptors in a rat insulin producing cell line (INS-1)Molecular and Cellular Endocrinology, 1995
- Glucocorticoids increase amylase mRNA levels, secretory organelles, and secretion in pancreatic acinar AR42J cells.Journal of Cell Biology, 1985